<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xml:lang="en" article-type="research-article" dtd-version="1.4"><!--The publisher of this article does not allow downloading of the full text in XML form.--><front><journal-meta><journal-id journal-id-type="nlm-ta">J Addict Med</journal-id><journal-id journal-id-type="iso-abbrev">J Addict Med</journal-id><journal-id journal-id-type="pmc-domain-id">319</journal-id><journal-id journal-id-type="pmc-domain">nihpa</journal-id><journal-title-group><journal-title>Journal of addiction medicine</journal-title></journal-title-group><issn pub-type="ppub">1932-0620</issn><issn pub-type="epub">1935-3227</issn><custom-meta-group><custom-meta><meta-name>pmc-is-collection-domain</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-collection-title</meta-name><meta-value>NIHPA Author Manuscripts</meta-value></custom-meta></custom-meta-group></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC10248186</article-id><article-id pub-id-type="pmcid-ver">PMC10248186.1</article-id><article-id pub-id-type="pmcaid">10248186</article-id><article-id pub-id-type="pmcaiid">10248186</article-id><article-id pub-id-type="manuscript-id">NIHMS1874262</article-id><article-id pub-id-type="pmid">37267181</article-id><article-id pub-id-type="doi">10.1097/ADM.0000000000001123</article-id><article-id pub-id-type="manuscript-id-alternative">NIHMS1874262</article-id><article-id pub-id-type="manuscript-id-alternative">NIHPA1874262</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>IMPACT OF PRENATAL CANNABIS USE DISORDER ON PERINATAL OUTCOMES</article-title></title-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Prewitt</surname><given-names initials="KC">Kristin C.</given-names></name><degrees>MD MPH</degrees><xref rid="A1" ref-type="aff">1</xref><xref rid="FN3" ref-type="author-notes">*</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Hayer</surname><given-names initials="S">Sarena</given-names></name><degrees>MD MA MSc</degrees><xref rid="A1" ref-type="aff">1</xref><xref rid="FN3" ref-type="author-notes">*</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Garg</surname><given-names initials="B">Bharti</given-names></name><degrees>MBBS MPH</degrees><xref rid="A1" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Benson</surname><given-names initials="AE">Ashley E.</given-names></name><degrees>MD MA MSc</degrees><xref rid="A1" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Hedges</surname><given-names initials="MA">Madeline A.</given-names></name><xref rid="A2" ref-type="aff">2</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Caughey</surname><given-names initials="AB">Aaron B.</given-names></name><degrees>MD PhD</degrees><xref rid="A1" ref-type="aff">1</xref><xref rid="FN4" ref-type="author-notes">#</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Lo</surname><given-names initials="JO">Jamie O.</given-names></name><degrees>MD MCR</degrees><xref rid="A1" ref-type="aff">1</xref><xref rid="FN4" ref-type="author-notes">#</xref></contrib></contrib-group><aff id="A1"><label>1</label>Department of Obstetrics and Gynecology, Oregon Health &amp; Science University, Portland, OR, USA</aff><aff id="A2"><label>2</label>Department of Pediatrics, Oregon Health &amp; Science University, Portland, OR, USA</aff><author-notes><fn fn-type="con" id="FN1"><p id="P1">AUTHOR CONTRIBUTIONS</p><p id="P2">Kristin Prewitt: Conceptualization, Investigation, Data curation, Formal Analysis, Writing &#8211; review and editing. Sarena Hayer: Conceptualization, Investigation, Data curation, Formal Analysis, Writing &#8211; review and editing. Bharti Garg: Validation, Formal analysis, Writing &#8211; review and editing. Ashley Benson: Writing &#8211; review and editing. Madeline Hedges: Writing &#8211; review and editing, Figure Design. Aaron Caughey: Study design, Supervision, Writing &#8211; review and editing. Jamie Lo: Conceptualization, Methodology, Validation, Investigation, Resources, Data curation, Formal Analysis, Writing &#8211; original draft, and Visualization.</p></fn><fn fn-type="equal" id="FN3"><label>*</label><p id="P3">Authors contributed equally to this work</p></fn><fn fn-type="equal" id="FN4"><label>#</label><p id="P4">Authors contributed equally to this work</p></fn><corresp id="CR1"><bold>Corresponding Author:</bold> Jamie Lo, MD, Department of Obstetrics and Gynecology, Oregon Health &amp; Science University, 3181 SW Sam Jackson Park Road, Mail Code L458, Portland, Oregon 97239, Work Phone: (503) 494-2101, Home Phone: (503) 679-2025, Fax: (503) 494-5296, <email>loj@ohsu.edu</email></corresp><fn fn-type="COI-statement" id="FN6"><p id="P28"><bold>Conflict of Interest Statement:</bold> None</p></fn></author-notes><pub-date pub-type="ppub"><season>May-Jun</season><year>2023</year></pub-date><pub-date pub-type="epub"><day>13</day><month>12</month><year>2022</year></pub-date><volume>17</volume><issue>3</issue><issue-id pub-id-type="pmc-issue-id">437681</issue-id><fpage>e192</fpage><lpage>e198</lpage><pub-history><event event-type="nihms-submitted"><date><day>17</day><month>02</month><year>2023</year></date></event><event event-type="pmc-release"><date><day>01</day><month>01</month><year>2024</year></date></event><event event-type="pmc-live"><date><day>01</day><month>01</month><year>2024</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2024-09-18 18:25:20.670"><day>18</day><month>09</month><year>2024</year></date></event></pub-history><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="nihms-1874262.pdf"/><abstract id="ABS1"><sec id="S1"><title>Objective:</title><p id="P5">With legislative changes to cannabis legalization and increasing prevalence of use, cannabis is the most commonly used federally illicit drug in pregnancy. Our study aims to assess the perinatal outcomes associated with prenatal cannabis use disorder.</p></sec><sec id="S2"><title>Methods:</title><p id="P6">We conducted a retrospective cohort study using California linked hospital discharge-vital statistics data and included singleton, non-anomalous births occurring between 23 to 42 weeks gestational age. Chi-squared and multivariable logistic regression were utilized for statistical analyses.</p></sec><sec id="S3"><title>Results:</title><p id="P7">A total of 2,380,446 patients were included and 9,144 (0.38%) were identified as using cannabis during pregnancy. There was a significantly increased risk for adverse birthing person outcomes, including gestational hypertension (aOR 1.19, 95% CI 1.06&#8211;1.34; p = 0.004), preeclampsia (aOR 1.16, 95% CI 1.0&#8211;1.28; p=0.006), preterm delivery (aOR 1.45, 95% CI 1.35&#8211;1.55; p&lt;0.001), and severe maternal morbidity (aOR 1.22, 95% CI 1.02&#8211;1.47; p=0.033). Prenatal cannabis use disorder was also associated with an increased risk of neonatal outcomes including respiratory distress syndrome (aOR 1.16, 95% CI 1.07&#8211;1.27; p&lt;0.001), small for gestational age (aOR 1.47, 95% CI 1.38&#8211;1.56; p&lt;0.001), neonatal intensive care unit admission (aOR 1.24, 95% CI 1.16&#8211;1.33; p&lt;0.001), and infant death (aOR 1.86, 95% CI 1.44&#8211;2.41; p&lt;0.001). There was no statistically significant difference in stillbirth (aOR 0.96, 95% CI 0.69&#8211;1.34; p=0.80) and hypoglycemia (aOR 1.22, 95% CI 1.00&#8211;1.49; p=0.045)</p></sec><sec id="S4"><title>Conclusion:</title><p id="P8">Our study suggests that prenatal cannabis use disorder is associated with increased maternal and neonatal morbidity and mortality. As cannabis use disorder in pregnancy is becoming more prevalent, our findings can help guide preconception and prenatal counseling.</p></sec></abstract><kwd-group><kwd>cannabis</kwd><kwd>marijuana</kwd><kwd>neonatal</kwd><kwd>fetal</kwd><kwd>pregnancy</kwd></kwd-group><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta></custom-meta-group></article-meta></front></article></pmc-articleset>